RecruitingNot ApplicableNCT06776731

Hyperoxia During Outpatient Pulmonary Rehabilitation in Chronic Lung Disease - Does it Matter?


Sponsor

Eastern Switzerland University of Applied Sciences

Enrollment

32 participants

Start Date

Jan 6, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Chronic obstructive pulmonary disease (COPD) is a global burden. Treatment options have improved in recent years, pulmonary rehabilitation plays a key role. Oxygen therapy is recommended in patients with a low saturation at rest, but no clear guidance is given for patients who desaturate during exercise. The effect of ambulatory oxygen during exercise is not yet completely understood, especially in those patients with exercise-induced desaturation. Aim: Evaluate the effect of supplemental oxygen therapy during a 3-months long ambulatory pulmonary rehabilitation program on exercise endurance. Patients will either receive supplemental oxygen therapy or room air during exercise training. Methods: A total of 32 patients with a confirmed diagnosis of COPD undergoing pulmonary rehabilitation will be included (male and female : aged ≥ 18 years; stable condition \&gt; 3 weeks (e.g. no exacerbations); resting oxygen saturation (SpO2) ≥ 88% and exercise induced hypoxemia defined by a fall in SpO2 by ≥ 4% and/ or below 90% during a 6-minute walking test). 3-months comprehensive PR for both intervention and control group including: education and awareness, instruction on inhalation therapies, smoking cessation counselling, respiratory and skeletal muscle training in groups, guided walks / cycle ergometer training. The intervention group will be trained using SSOT and the control group will receive sham air (ambient air). Patients and assessors will be blinded. Between group difference in cycling constant work rate exercise test (CWRET) time from baseline to 3 months SSOT (5l/min) vs ambient air will be the primary outcome of this study. Data will be summarized by means (SD) and medians (quartiles) for normal and non-normal distributions. Effects of treatment will be evaluated by mean differences with 95% confidence intervals, T-tests or Wilcoxon matched pair tests as appropriate. A p-value threshold of \<0.05 or a confidence interval not including zero will be considered as statistically significant. Analyses will be performed according to the intention to treat principle.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether giving supplemental oxygen during exercise in pulmonary rehabilitation helps people with COPD (a lung disease) who experience a drop in oxygen levels during physical activity. The study compares exercising with extra oxygen versus regular air to see which leads to better outcomes. **You may be eligible if...** - You are 18 years or older - You have confirmed COPD (with a relevant lung function test result) - You have a significant smoking history (10+ pack-years) - You are enrolled in outpatient pulmonary rehabilitation - Your oxygen levels drop during a 6-minute walk test (exercise-induced low oxygen) - Your resting oxygen level is 88% or above - Your condition has been stable for at least 3 weeks **You may NOT be eligible if...** - Your resting oxygen level is below 88% - You are already on long-term oxygen therapy - You have a serious unstable condition that requires changing your current treatment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEROxygen

Standard supplemental Oxygen therapy (5l/min) will be applied with an oxygen concentrator via nasal cannula during endurance training.

OTHERRoom Air (placebo)

Room air (5l/min) will be applied with an oxygen concentrator via nasal cannula during endurance training.


Locations(1)

Kantonsspital Winterthur

Winterthur, Canton of Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06776731


Related Trials